These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19785825)

  • 21. [On the treatment of depression with a new dibenzodiazepine derivative].
    Schigutt R; Suchanek-Fröhlich H
    Wien Klin Wochenschr; 1965 Sep; 77(35):584-6. PubMed ID: 5858768
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of prevalence of depression in an epilepsy clinic using a brief DSM-IV-based self-report questionnaire.
    Seminario NA; Farias ST; Jorgensen J; Bourgeois JA; Seyal M
    Epilepsy Behav; 2009 Jul; 15(3):362-6. PubMed ID: 19525150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rater and rating instrument as sources of variance in evaluating drug efficacy in depression.
    Raskin A; Crook T
    Psychopharmacol Bull; 1975 Jul; 11(3):16-7. PubMed ID: 1153643
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of rating scales in the use of antidepressants.
    Zung WW
    Dis Nerv Syst; 1976 Mar; 37(3 PT 2):22-4. PubMed ID: 1253669
    [No Abstract]   [Full Text] [Related]  

  • 25. [Research report 'the appropriate prescribing of antidepressants in general practice': who is better served by more diagnoses and more antidepressants?].
    van Weel-Baumgarten EM
    Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1275-7. PubMed ID: 16821449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
    Hashimoto K
    J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
    [No Abstract]   [Full Text] [Related]  

  • 27. Treating depression: psychiatric consultation in cardiology.
    Nickels MW; Privitera MR; Coletta M; Sullivan P
    Cardiol J; 2009; 16(3):279-93. PubMed ID: 19437407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient's guide to medication used for depression.
    Schaffer SD
    Lippincotts Prim Care Pract; 2000; 4(2):237-9. PubMed ID: 11143634
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug utilization by the elderly with depressive symptoms].
    de Lange-de Klerk ES
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1475-6. PubMed ID: 11503320
    [No Abstract]   [Full Text] [Related]  

  • 30. [The debate concerning the classification of depression that predominantly occurred in the United Kingdom from 1926 to 1957: the discovery and reappraisal of "mild endogenous depression"].
    Ohmae S
    Seishin Shinkeigaku Zasshi; 2009; 111(5):486-501. PubMed ID: 19624094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The concept of depression and evaluation of the effect of antidepressive agents].
    Licht RW
    Ugeskr Laeger; 1996 Jun; 158(23):3332-3. PubMed ID: 8686067
    [No Abstract]   [Full Text] [Related]  

  • 32. Melancholia as a useful subtype of major depression.
    Solomon DA
    J Clin Psychiatry; 2009 Sep; 70(9):1326. PubMed ID: 19818258
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on partial response in depression.
    Thase ME
    J Clin Psychiatry; 2009; 70 Suppl 6():4-9. PubMed ID: 19922738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids for CHD with depression.
    Anghelescu I
    JAMA; 2010 Mar; 303(9):836; author reply 836. PubMed ID: 20197529
    [No Abstract]   [Full Text] [Related]  

  • 35. The diagnosis and treatment of depression in the geriatric population.
    Khouzam HR
    Compr Ther; 2009; 35(2):103-14. PubMed ID: 19618759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of depression in the last month of life.
    Eychmueller S
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):186-9. PubMed ID: 19561508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can there be a 'cosmetic' psychopharmacology? Prozac unplugged: the search for an ontologically distinct cosmetic psychopharmacology.
    Bjorklund P
    Nurs Philos; 2005 Apr; 6(2):131-43. PubMed ID: 15787908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial treatment approaches for patients with major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Algorithm-guided treatment versus treatment as usual for major depression.
    Yoshino A; Sawamura T; Kobayashi N; Kurauchi S; Matsumoto A; Nomura S
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):652-7. PubMed ID: 19674382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Should the treatment of depression in the Netherlands be changed after the STAR*D study?].
    Paalvast Y; Nolen WA
    Tijdschr Psychiatr; 2008; 50(4):223-8. PubMed ID: 18398802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.